$ALXN ALEXION PHARMACEUTICALS, INC. Insider Trading
Get free email notifications about insider trading in ALEXION PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ALEXION PHARMACEUTICALS, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in ALEXION PHARMACEUTICALS, INC. for free.
CIK Number: 0000899866
IRS Number: 133648318
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ALXN
Company Address: 121 SEAPORT BOULEVARD BOSTON 02210
Former name: ALEXION PHARMACEUTICALS INC, date of change: 1996-01-11
Market Capitalization: $28.30B
Prev close: $127.72
Average Daily Volume: 2,978,680
Days Low: $125.69
Year Low: $109.12
Year High: $162.00
ALEXION PHARMACEUTICALS, INC. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 24 2021 | ALXN | ALEXION PHARMACEUT ... | Brennan David R | Director | Grant | A | 0.00 | 1,374 | 0 | 20,873 | 19.5 K to 20.9 K (+7.05 %) |
May 24 2021 | ALXN | ALEXION PHARMACEUT ... | Brennan David R | Director | Grant | A | 0.00 | 1,962 | 0 | 19,499 | 17.5 K to 19.5 K (+11.19 %) |
Apr 01 2021 | ALXN | ALEXION PHARMACEUT ... | HANTSON LUDWIG | CEO | Payment of Exercise | F | 154.03 | 2,332 | 359,198 | 349,166 | 351.5 K to 349.2 K (-0.66 %) |
Mar 02 2021 | ALXN | ALEXION PHARMACEUT ... | SARIN ARADHANA | EVP, CFO | Grant | A | 0.00 | 24,473 | 0 | 63,940 | 39.5 K to 63.9 K (+62.01 %) |
Mar 02 2021 | ALXN | ALEXION PHARMACEUT ... | ORLOFF JOHN J | EVP, Research & Dev ... | Grant | A | 0.00 | 24,473 | 0 | 88,324 | 63.9 K to 88.3 K (+38.33 %) |
Mar 02 2021 | ALXN | ALEXION PHARMACEUT ... | Bazarko Daniel | SVP, Controller, CA ... | Grant | A | 0.00 | 7,616 | 0 | 38,499 | 30.9 K to 38.5 K (+24.66 %) |
Dec 21 2020 | ALXN | ALEXION PHARMACEUT ... | Bazarko Daniel | SVP, Controller, CA ... | Option Exercise | M | 140.16 | 11,000 | 1,541,760 | 0 | |
Dec 21 2020 | ALXN | ALEXION PHARMACEUT ... | Bazarko Daniel | SVP, Controller, CA ... | Option Exercise | M | 97.58 | 13,066 | 1,274,980 | 0 | |
Dec 21 2020 | ALXN | ALEXION PHARMACEUT ... | Bazarko Daniel | SVP, Controller, CA ... | Sell | S | 158.00 | 1,100 | 173,800 | 30,883 | 32 K to 30.9 K (-3.44 %) |
Dec 21 2020 | ALXN | ALEXION PHARMACEUT ... | Bazarko Daniel | SVP, Controller, CA ... | Sell | S | 157.76 | 13,066 | 2,061,292 | 31,983 | 45 K to 32 K (-29.00 %) |
Dec 21 2020 | ALXN | ALEXION PHARMACEUT ... | Bazarko Daniel | SVP, Controller, CA ... | Sell | S | 157.59 | 9,900 | 1,560,141 | 45,049 | 54.9 K to 45 K (-18.02 %) |
Dec 21 2020 | ALXN | ALEXION PHARMACEUT ... | Bazarko Daniel | SVP, Controller, CA ... | Buy | M | 140.16 | 11,000 | 1,541,760 | 54,949 | 43.9 K to 54.9 K (+25.03 %) |
Dec 21 2020 | ALXN | ALEXION PHARMACEUT ... | Bazarko Daniel | SVP, Controller, CA ... | Buy | M | 97.58 | 13,066 | 1,274,980 | 43,949 | 30.9 K to 43.9 K (+42.31 %) |
Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | HANTSON LUDWIG | CEO | Payment of Exercise | F | 157.96 | 13,059 | 2,062,800 | 267,773 | 280.8 K to 267.8 K (-4.65 %) |
Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | HANTSON LUDWIG | CEO | Payment of Exercise | F | 157.96 | 72,533 | 11,457,313 | 280,832 | 353.4 K to 280.8 K (-20.53 %) |
View all ALEXION PHARMACEUTICALS, INC. insider transactions.